Once-Daily Treatment With Atomoxetine in Adults With Attention-Deficit/Hyperactivity DisorderJoel Young, Linda Wietecha, Elias Sarkis et al.|Clinical Neuropharmacology|2011Cited by 61
Atomoxetine Increased Effect over Time in Adults with Attention‐Deficit/Hyperactivity Disorder Treated for up to 6 Months: Pooled Analysis of Two Double‐Blind, Placebo‐Controlled, Randomized TrialsLinda Wietecha, Robert L. Findling, Elias Sarkis et al.|CNS Neuroscience & Therapeutics|2016Cited by 10
A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of AR19, a Manipulation-Resistant Formulation of Amphetamine Sulfate, in Adults With Attention-Deficit/Hyperactivity DisorderStephen V. Faraone, Joel Young, Steve Caras et al.|The Journal of Clinical Psychiatry|2021Cited by 3